Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > News?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(186)
•••
Comment by robertshawon Feb 09, 2022 12:11pm
477 Views
Post# 34412888

RE:RE:RE:News?

RE:RE:RE:News?
robertshaw wrote:
Yajne wrote: Update on Ph2 trial expected "SOON" which will confirm the data needed to apply for break through designation (BTD) for TLD-1433. IMO this will propel sp above $1 initially and possibly significantly higher depending on the full content of the long-awaited NR. JMHO

Nunavuttrader wrote: When do we expect big news? What are the predictions of where this stock could go and in what timeframe?


 

 
if we could get the former 7 patients (270 days cancer free) all printed out  to be  360 days cancer free( and the former 7 patients which are 180 days cancer free to 270 days cancer free), by the end of this month, we can see $30+ before BTD comes....

Blowjobjoe once bet against  me in Phase1 for the 5th patient 's 270 days cancer free result after we got the 5th patient 180 days cancer free, I said 270 days cancer free after 180 days cancer free is a given, he insisited no so sure.... but I won...and it did turned out to be 270 days cancer free when the time hit..., 

I miss Blowjobjoe, because no one dare to bet like him against science now.. , bet against science ,  need a lots courage.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities